Summit Therapeutics (SMMT)
NASDAQ:SMMT
Want to see SMMT full AI Analyst Report?
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 23, 2025 | xxxxxxxxxxxxx | $499983 | |
Oct 23, 2025 | xxxxxxxxxxxxx | $499983 | |
Oct 23, 2025 | xxxxxxxxxxxxx | $9999983 | |
Sep 11, 2025 | xxxxxxxxxxxxx | $5984756 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $636479691 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 606,105,809 | Insider | 78.17% | 11,922,101,263 | |
| 606,105,809 | Insider | 78.17% | 11,922,101,263 | |
| 36,391,063 | Institution | 4.69% | 715,812,209 | |
| 32,057,147 | Insider | 4.13% | 630,564,081 | |
| 10,131,337 | Institution | 1.31% | 199,283,399 | |
| 9,308,006 | Institution | 1.20% | 183,088,478 | |
| 7,286,202 | Institution | 0.94% | 143,319,593 | |
| 5,387,605 | Institution | 0.69% | 105,974,190 | |
| 4,222,878 | Institution | 0.54% | 83,064,010 | |
| 3,345,789 | Institution | 0.43% | 65,811,670 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,308,006 | Institution | 1.20% | 183,088,478 | |
| 7,286,202 | Institution | 0.94% | 143,319,593 | |
| 3,345,789 | Institution | 0.43% | 65,811,670 | |
| 2,993,695 | Institution | 0.39% | 58,885,981 | |
| 2,073,105 | Institution | 0.27% | 40,777,975 | |
| 1,836,899 | Institution | 0.24% | 36,131,803 | |
| 829,400 | Institution | 0.11% | 16,314,298 | |
| 768,084 | Institution | 0.10% | 15,108,212 | |
| 487,479 | Institution | 0.06% | 9,588,712 | |
| 450,036 | Institution | 0.06% | 8,852,208 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,387,605 | Institution | 0.69% | 104,034,653 | |
| 3,547,137 | Institution | 0.46% | 58,847,003 | |
| 2,534,686 | Institution | 0.33% | 42,050,441 | |
| 1,628,337 | Institution | 0.21% | 27,014,111 | |
| 1,626,630 | Institution | 0.21% | 26,985,792 | |
| 805,294 | Institution | 0.10% | 15,840,133 | |
| 778,635 | Institution | 0.10% | 15,315,750 | |
| 586,662 | Institution | 0.08% | 11,328,443 | |
| 482,911 | Institution | 0.06% | 9,498,859 | |
| 463,688 | Institution | 0.06% | 7,692,584 |
FAQ
Who Owns Summit Therapeutics (SMMT)?
Currently, no data Available
What percentage of Summit Therapeutics (SMMT) stock is held by institutional investors?
Currently, no data Available
What percentage of Summit Therapeutics (SMMT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Summit Therapeutics (SMMT)?
Robert Duggan owns the most shares of Summit Therapeutics (SMMT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.